TMEM37 and chronic myelogenous leukemia, BCR-ABL1 positive: In patients with CML, the bone marrow had a higher number of anti-PR1 TCR clones than peripheral blood (median 686 vs 92, log2FC = 2.899, P = 8.9 × 10−10), and these also occupied the larger part of the repertoire (median % of total TCR repertoire 4.33% vs 0.743%, log2FC = 2.543, P = 1.7 × 10−8, Fig. 5f, Supplementary Fig. 11c).